This company has been marked as potentially delisted and may not be actively trading. XTL Biopharmaceuticals (XTLB) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsEarningsHeadlinesShort InterestTrendsBuy This Stock XTLB vs. NNVC, CARA, TENX, OVID, IMNN, GDTC, CASI, LSTA, ENLV, and QTTBShould you be buying XTL Biopharmaceuticals stock or one of its competitors? The main competitors of XTL Biopharmaceuticals include NanoViricides (NNVC), Cara Therapeutics (CARA), Tenax Therapeutics (TENX), Ovid Therapeutics (OVID), Imunon (IMNN), CytoMed Therapeutics (GDTC), CASI Pharmaceuticals (CASI), Lisata Therapeutics (LSTA), Enlivex Therapeutics (ENLV), and Q32 Bio (QTTB). These companies are all part of the "pharmaceutical preparations" industry. XTL Biopharmaceuticals vs. Its Competitors NanoViricides Cara Therapeutics Tenax Therapeutics Ovid Therapeutics Imunon CytoMed Therapeutics CASI Pharmaceuticals Lisata Therapeutics Enlivex Therapeutics Q32 Bio NanoViricides (NYSE:NNVC) and XTL Biopharmaceuticals (NASDAQ:XTLB) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, profitability, valuation, analyst recommendations, media sentiment, earnings, risk, community ranking and dividends. Which has higher earnings and valuation, NNVC or XTLB? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNanoViricidesN/AN/A-$8.29M-$0.70-2.16XTL BiopharmaceuticalsN/AN/A-$1.78MN/AN/A Which has more risk and volatility, NNVC or XTLB? NanoViricides has a beta of 0.91, indicating that its share price is 9% less volatile than the S&P 500. Comparatively, XTL Biopharmaceuticals has a beta of 1.13, indicating that its share price is 13% more volatile than the S&P 500. Does the media prefer NNVC or XTLB? In the previous week, XTL Biopharmaceuticals had 1 more articles in the media than NanoViricides. MarketBeat recorded 2 mentions for XTL Biopharmaceuticals and 1 mentions for NanoViricides. XTL Biopharmaceuticals' average media sentiment score of 0.00 beat NanoViricides' score of -1.00 indicating that XTL Biopharmaceuticals is being referred to more favorably in the news media. Company Overall Sentiment NanoViricides Negative XTL Biopharmaceuticals Neutral Do institutionals & insiders have more ownership in NNVC or XTLB? 10.3% of NanoViricides shares are owned by institutional investors. Comparatively, 4.4% of XTL Biopharmaceuticals shares are owned by institutional investors. 4.6% of NanoViricides shares are owned by insiders. Comparatively, 29.0% of XTL Biopharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Does the MarketBeat Community believe in NNVC or XTLB? XTL Biopharmaceuticals received 79 more outperform votes than NanoViricides when rated by MarketBeat users. Likewise, 71.82% of users gave XTL Biopharmaceuticals an outperform vote while only 0.00% of users gave NanoViricides an outperform vote. CompanyUnderperformOutperformNanoViricidesOutperform VotesNo VotesUnderperform Votes57100.00% XTL BiopharmaceuticalsOutperform Votes7971.82% Underperform Votes3128.18% Is NNVC or XTLB more profitable? XTL Biopharmaceuticals' return on equity of 0.00% beat NanoViricides' return on equity.Company Net Margins Return on Equity Return on Assets NanoViricidesN/A -87.90% -78.69% XTL Biopharmaceuticals N/A N/A N/A SummaryXTL Biopharmaceuticals beats NanoViricides on 9 of the 10 factors compared between the two stocks. Get XTL Biopharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for XTLB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding XTLB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart XTLB vs. The Competition Export to ExcelMetricXTL BiopharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.16M$6.87B$5.57B$8.50BDividend YieldN/A2.53%5.28%4.16%P/E RatioN/A8.4326.6319.64Price / SalesN/A262.52407.99152.17Price / CashN/A65.8538.2534.64Price / Book3.126.536.964.60Net Income-$1.78M$143.25M$3.23B$248.06M XTL Biopharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)XTLBXTL Biopharmaceuticals0.1837 of 5 stars$1.28+13.3%N/AN/A$6.16MN/A0.00N/ANNVCNanoViricides0.1837 of 5 stars$1.52-1.3%N/A-40.8%$24.43MN/A-2.1120Short Interest ↑CARACara Therapeutics0.2859 of 5 starsN/A$36.00+∞N/A$24.33M$7.14M-0.2580Gap DownHigh Trading VolumeTENXTenax Therapeutics1.6415 of 5 stars$5.86-3.3%$17.50+198.6%+74.8%$24.31MN/A-2.369Positive NewsOVIDOvid Therapeutics4.3825 of 5 stars$0.33+4.0%$2.78+740.4%-91.2%$23.55M$548K-0.7060High Trading VolumeIMNNImunon1.9109 of 5 stars$1.33-8.9%$15.50+1,065.4%+19.7%$23.33M$500K-0.7030Short Interest ↑Gap DownGDTCCytoMed Therapeutics2.5918 of 5 stars$2.12+3.2%$5.00+136.4%+3.5%$23.14M$69.50K0.00N/APositive NewsCASICASI Pharmaceuticals4.1886 of 5 stars$1.86-0.4%$4.00+115.6%-43.6%$22.82M$31.37M-0.83180Positive NewsGap DownLSTALisata Therapeutics2.4284 of 5 stars$2.63-2.2%$15.00+470.3%-27.8%$22.66M$1M-1.0530Positive NewsGap UpENLVEnlivex Therapeutics3.463 of 5 stars$0.94-2.8%$10.00+963.8%-38.8%$22.23MN/A-0.9670News CoverageQTTBQ32 Bio3.4094 of 5 stars$1.82-4.2%$24.71+1,257.9%-91.5%$22.20M-$6.65M-0.1339Short Interest ↓Gap Up Related Companies and Tools Related Companies NanoViricides Competitors Cara Therapeutics Competitors Tenax Therapeutics Competitors Ovid Therapeutics Competitors Imunon Competitors CytoMed Therapeutics Competitors CASI Pharmaceuticals Competitors Lisata Therapeutics Competitors Enlivex Therapeutics Competitors Q32 Bio Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:XTLB) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGet in stocks now - and get out on this dateGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding XTL Biopharmaceuticals Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share XTL Biopharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy XTLB Stock Free XTLB Stock Alerts